Naghmeh Ahmadiankia

Naghmeh Ahmadiankia

Auto-generated profile, based on publicly available information

Naghmeh Ahmadiankia

Cancer Prevention Research Center, Shahroud University of Medical Sciences, Shahroud, Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2014 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
HNHojjat Naderi-Meshkin
Hojjat Naderi-Meshkin
ABAhmad Reza Bahrami
Ahmad Reza Bahrami
HBHamid Reza Bidkhori
Hamid Reza Bidkhori
MMMahdi Mirahmadi
Mahdi Mirahmadi
NANaghmeh Ahmadiankia
Naghmeh Ahmadiankia

27 April 2020 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
NANaghmeh Ahmadiankia
Naghmeh Ahmadiankia

13 August 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
HNHojjat Naderi-Meshkin
Hojjat Naderi-Meshkin
NANaghmeh Ahmadiankia
Naghmeh Ahmadiankia

1 February 2016
Verified
Journal Article
Open access
NANaghmeh Ahmadiankia
Naghmeh Ahmadiankia
HMHamid Kalalian Moghaddam
Hamid Kalalian Moghaddam
MMMohammad Amir Mishan
Mohammad Amir Mishan
ABAhmad Reza Bahrami
Ahmad Reza Bahrami
HNHojjat Naderi-Meshkin
Hojjat Naderi-Meshkin
SMSeyed Jamal Aldin Mirfeyzi
Seyed Jamal Aldin Mirfeyzi
Berberine is one of the main alkaloids and it has been proven to have different pharmacological effects including inhibition of cell cycle and progression of apoptosis in various cancerous cells; however, its effects on cancer metastasis are not well known. Cancer cells obtain the ability to change their chemokine system and convert into metastatic cells. In this study, we examined the effect of berberine on breast cancer cell migration and its probable interaction with the chemokine system in cancer cells. The MCF-7 breast cancer cell line was cultured, and then, treated with berberine (10, 20, 40 and 80 μg/ml) for 24 hr. MTT assay was used in order to determine the cytotoxic effect of berberine on MCF-7 breast cancer cells. Wound healing assay was applied to determine the inhibitory effect of berberine on cell migration. Moreover, real-time quantitative PCR analysis of selected chemokine receptors was performed to determine the probable molecular mechanism underlying the effect of berberine on breast cancer cell migration. The results of wound healing assay revealed that berberine decreases cell migration. Moreover, we found that the mRNA levels of some chemokine receptors were reduced after berberine treatment, and this may be the underlying mechanism for decreased cell migration. Our results indicate that berberine might be a potential preventive biofactor for human breast cancer metastasis by targeting chemokine receptor genes.

1 September 2019
Verified
Journal Article
Open access
PDF file
NANaghmeh Ahmadiankia
Naghmeh Ahmadiankia
Metastasis is the primary cause of mortality and morbidity among cancer patients and accounts for about 90% of cancer deaths. The most common types of treatment for cancer metastasis are chemotherapy and radiotherapy. However, such therapy has many serious side effects that could diminish the quality of life in patients. There is increased appreciation by the scientific community that natural compounds can be potential weapons in fighting against cancer. Interestingly, much evidence shows that pomegranate (Punica granatum) has great potential to inhibit tumor growth and metastasis. In this review, we discussed the molecular targets of pomegranate, specifically, those that are prerequisite for cancer metastasis. The search was performed in Google Scholar, Medline, Scopus, and PubMed using keywords such as metastasis, pomegranate, and signaling pathways. Some of the most important papers from the search results were included. Based on recent studies, some molecules, including those involved in cell-cell and cell-extracellular matrix adhesions, are affected by pomegranate. The other targets of pomegranate are modulators of cytoskeleton dynamics and regulators of cancer cell anoikis and chemotaxis. Furthermore, the antimetastatic effect of pomegranate may be attributed to molecular changes of the extracellular matrix. Pro-inflammatory and pro-angiogenic molecules are the other targets of pomegranate regarding cancer metastasis. A wide variety of molecules can be targeted by pomegranate to suppress tumor metastasis. A better understanding of the molecules regulated by pomegranate is needed to provide a rational basis for its clinical application.

1 January 2020 in Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PDF file
NANaghmeh Ahmadiankia
Naghmeh Ahmadiankia
AKAhmad Khosravi
Ahmad Khosravi
Background: The clinical relevance of epithelial-to-mesenchymal transition (EMT) in colorectal cancer (CRC) progression has been highlighted over the last decade. Several EMT-inducing transcription factors (EMT-TFs) have been implicated in the regulation of EMT, including Twist, Snail1, Slug, ZEB1, and ZEB2. Here, this meta-analysis aimed to predict the risk of distance metastasis and overall survival in CRC patients with high expression of EMT-TFs. Materials and Methods: All eligible studies were searched in PubMed, Scopus, and Web of Science databases. The search was carried out to include literatures published as late as September 1, 2018. In overall, 16 studies that investigated the relationship between EMT-TFs with distance metastasis and survival in CRC patients were included. In meta-analysis, a pooled hazard ratio (HR) and odds ratio (OR) were estimated for associations. Results: The results of this review indicated that expressions of all EMT-TFs are significantly correlated with poor overall survival in CRC. Moreover, there are a significant association between Twist (OR, 1.46; 95% confidence interval [CI], 1.03–2.09), Slug (OR, 3.43; 95% CI, 1.98–5.93), and ZEB2 (OR, 2.42; 95% CI, 1.09–5.40) expression with distance metastatic in CRC patients. Conclusion: These findings suggest that the overexpression of EMT-TFs plays a key role in increasing the risk of distance metastasis as well as decreasing overall survival in CRC patients.